Mika Rathwell
Overview
Explore the profile of Mika Rathwell including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
4
Citations
7
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Malkin J, Jessiman-Perreault G, Alberga Machado A, Teare G, Snider J, Tirmizi S, et al.
JMIR Public Health Surveill
. 2024 Mar;
10():e45508.
PMID: 38536211
Background: Human papillomavirus (HPV) infection causes nearly all cervical cancer cases and is a cause of anogenital and oropharyngeal cancers. The incidence of HPV-associated cancers is inequitable, with an increased...
2.
Dionne M, Sauvageau C, Kiely M, Dahhou M, Hamel D, Rathwell M, et al.
Vaccine
. 2023 Dec;
42(1):17-23.
PMID: 38044245
Background: HPV vaccination prevents cancers, including 90% of cervical cancer. Since 2008, a school-based HPV vaccination program has been implemented in Quebec, but vaccine coverage is suboptimal. The COVID-19 pandemic...
3.
Dionne M, Sauvageau C, Kiely M, Rathwell M, Bandara T, Neudorf C, et al.
Vaccine
. 2023 Sep;
41(45):6654-6660.
PMID: 37777452
Background: HPV vaccination has been offered in school programs for over a decade in Quebec, Canada, but the vaccine coverages are not reaching the target coverage in several regions. This...
4.
Malkin J, Allen Scott L, Alberga Machado A, Teare G, Snider J, Tirmizi S, et al.
PLoS One
. 2022 Dec;
17(12):e0278472.
PMID: 36454791
More than 1,300 Canadians are diagnosed with cervical cancer annually, which is nearly preventable through human papillomavirus (HPV) immunization. Across Canada, coverage rates remain below the 90% target set out...